RTI Health Solutions
UnclaimedRTI Health Solutions provides research and consulting services to help life science and healthcare stakeholders make evidence-based decisions.
Overview
RTI Health Solutions is an independent, nonprofit research and consulting organization serving life science and healthcare stakeholders. Its multidisciplinary researchers provide scientific evidence, strategic advice, and communication support to help pharmaceutical, biotechnology, and medical device organizations address development, regulatory, market access, safety, and patient-outcome questions. The organization combines rigorous research methods with industry context to support evidence-based healthcare decisions.
Mission statement
To improve the human condition by turning knowledge into practice.
One of 5 AI agents in Healthcare Research
Work at RTI Health Solutions? Decide what AI assistants read about you.
Claim RTI Health SolutionsUse your email at rtihs.org.What we offer
Value, Access, and HEOR Consulting
Helps life sciences and medtech teams demonstrate product value, navigate market access requirements, and support reimbursement decisions with evidence.
rtihs.org →Patient-Centered Research
Turns patient perspectives and preferences into evidence that supports product development, regulatory decisions, and strategic choices.
rtihs.org →Regulatory and safety consulting
Generates rigorous safety and regulatory evidence to guide product development, support submissions, and inform post-approval decisions.
rtihs.org →Medical Communications
Turns complex evidence into clear, credible communications that inform audiences, support scientific exchange, and advance understanding across the product lifecycle.
rtihs.org →Real-world evidence research and consulting
Generates and applies real-world evidence to inform product development, regulatory decisions, market access, reimbursement, and outcomes research.
rtihs.org →Medical Affairs Solutions
Aligns evidence, communications, and stakeholder engagement to support informed healthcare decisions and stronger launch and lifecycle execution.
rtihs.org →Joint Clinical Assessment Services
Prepares stronger EU JCA submissions with strategic planning, robust evidence generation, and support adapting to assessment scope and national HTA needs.
rtihs.org →Implementation science services
Anticipates adoption challenges and aligns evidence, stakeholders, and healthcare systems so innovations can reach patients in real-world practice.
rtihs.org →Market segments
Market size by segment
Growth potential (CAGR)
Health economics and market access consulting
Research and consulting that help life sciences companies demonstrate clinical and economic value, prepare health technology assessments, and support pricing, reimbursement, and market access decisions.
Products: Value, Access, and HEOR Consulting, Joint Clinical Assessment Services
Real-world evidence
Capabilities to aggregate, link, and analyze clinical and claims data to generate evidence for clinical research, regulatory submissions, and lifecycle evidence generation.
Products: Real-world evidence research and consulting, Regulatory and safety consulting, Value, Access, and HEOR Consulting
Patient-centered outcomes research
Research that helps product developers incorporate patient perspectives, develop and validate clinical outcome assessments, quantify treatment preferences, and support regulatory claims and benefit-risk decisions.
Products: Patient-Centered Research, Regulatory and safety consulting
Regulatory affairs and drug safety consulting
Scientific and strategic support for life sciences companies preparing regulatory submissions, engaging agencies, assessing benefit-risk, and meeting post-authorization safety and evidence requirements.
Products: Regulatory and safety consulting, Real-world evidence research and consulting
Medical affairs and scientific communications
Services that help life sciences teams plan medical strategy, communicate scientific evidence, educate and engage stakeholders, and address implementation barriers to product adoption across the lifecycle.
Products: Medical Affairs Solutions, Medical Communications, Implementation science services
More information about our offering
Value, Access, and HEOR Consulting
RTI Health Solutions provides value, access, and HEOR consulting and research for pharmaceutical, biotechnology, and medtech companies. Services help teams assess and communicate product value, evaluate market access considerations, and support reimbursement decisions throughout the product lifecycle. The work spans health economics, value and access strategy, HTA and reimbursement submissions, and outcomes research, using methods such as economic modeling, real-world data, statistical analysis, and primary research.
- Assess Value And Inform Economic DecisionsBuilds evidence-based assessments of product value to inform healthcare decisions, market access, reimbursement, and HTA submissions.
- Develop Submissions For Global Market AccessHelps pharmaceutical and medtech companies prepare submissions and dossiers that demonstrate product value, meet payer needs, and address global market access requirements.
- Guide Product Value And Access PlanningSupports clinical and commercial teams in shaping evidence-based strategies and tactics to communicate product value and pursue market access.
- Present Evidence To Healthcare Decision-MakersProvides structured, evidence-based dossiers that communicate product value to stakeholders and support payer formulary decisions.
- Identify Evidence Needs For ReimbursementClarifies where additional evidence generation can support reimbursement decisions and improve product access.
- Communicate Product Value To Relevant AudiencesTurns research findings and value messages into communication materials intended to support understanding and adoption by relevant audiences.
- Understand Decision-Maker PerspectivesSurfaces expert and stakeholder perspectives that can inform pricing, reimbursement, access, evidence planning, and product strategy.
- Evaluate Real-World Product OutcomesProvides evidence about how products are used and their value and safety in real-world settings to inform product and healthcare decisions.
- Synthesize Evidence And Identify GapsBrings together existing research to clarify what is known, reveal evidence gaps, and support development and healthcare decisions.
- Generate Evidence Across Research QuestionsUses a range of research methods and data sources to address questions about product development, market access, reimbursement, treatment effectiveness, and healthcare decision-making.
- Address Pricing And ICER ConsiderationsSupports product value and pricing considerations in relation to ICER's evolving landscape.
- Address Equity Across The Product LifecycleIntegrates health equity considerations with innovation across the pharmaceutical lifecycle.
Patient-Centered Research
RTI Health Solutions’ patient-centered research services capture, quantify, and apply the patient perspective throughout the product lifecycle. The multidisciplinary team develops actionable patient, provider, and caregiver insights to support product development, regulatory submissions, and strategic decision-making. Services include clinical outcome assessment strategy and development, patient-reported outcomes research, health preference studies, and benefit-risk assessment.
- Apply Patient Perspectives To DecisionsUses actionable insights from patients, providers, and caregivers to inform product development, regulatory submissions, and strategic decisions.
- Align Outcomes With Patient And Regulatory NeedsDevelops a clinical outcome assessment strategy that reflects patient experience while aligning with regulatory requirements.
- Develop And Validate Outcome MeasuresCreates or adapts outcome measures that reflect patient experiences and support product approval and labeling claims.
- Quantify Patient Treatment PreferencesClarifies patient priorities and treatment trade-offs to inform product development, positioning, and regulatory decisions.
- Capture Patient Outcomes Across Research SettingsCollects patient-reported information in clinical trials, observational studies, and clinical practice to support product claims, market access, and patient-clinician communication.
- Balance Product Benefits And RisksAssesses product benefits and risks in a way that addresses regulatory, reimbursement, and healthcare provider needs.
- Identify Evidence GapsReviews existing scientific findings to clarify what is known, identify gaps, and inform development decisions.
Regulatory and safety consulting
RTI Health Solutions provides scientifically rigorous regulatory and safety consulting for pharmaceutical, biotech, and medical device companies. Its multidisciplinary team of pharmacoepidemiologists and biostatisticians supports product development, regulatory submissions, and post-approval activities through epidemiology research, statistical analysis, real-world evidence, and regulatory strategy. Services include evidence planning, submission preparation, regulatory agency interactions, post-authorization studies, and risk management support. Research approaches include observational studies, database and registry research, literature reviews, meta-analyses, and prospective studies.
- Assess Disease Patterns And Treatment ImpactUses epidemiologic research to examine disease indicators, treatment impact, and patient outcomes, supporting development, regulatory submissions, and post-market safety activities.
- Navigate Regulatory Requirements And SubmissionsProvides strategic and scientific guidance for evidence requirements, submission preparation, and regulatory agency interactions throughout product development and after authorization.
- Analyze Data For Regulatory DecisionsApplies statistical methods and tools to clinical trial and observational data to generate evidence for regulatory, safety, and market access decisions.
- Strengthen Post-Approval Safety EvidenceGenerates evidence about product safety and effectiveness after authorization while supporting regulatory obligations and post-approval strategies.
- Apply Real-World Evidence Across DevelopmentDevelops an approach to using real-world data at different stages of product development and supports regulatory decision-making and post-approval activities.
- Develop And Support Outcome MeasuresDevelops or revises outcome measures and supporting evidence with attention to regulatory agency expectations and their use in clinical trials and labeling strategies.
- Evaluate Product Benefits And RisksAssesses product benefits and risks to inform regulatory and healthcare decisions and address reimbursement and provider needs.
- Plan And Coordinate Rigorous StudiesAssesses study feasibility, develops scientifically rigorous and regulatorily aligned protocols, and coordinates pharmacoepidemiologic investigations from planning through delivery.
- Combine Data And Research ExpertiseDraws on research collaborations and multi-country real-world data to produce rigorous, transparent evidence supporting safety and effectiveness insights.
Medical Communications
RTI Health Solutions provides medical communications consulting and engagement strategy to translate complex clinical and scientific evidence into clear, audience-appropriate communications. Services span strategic planning, integrated evidence strategy, expert research, medical writing and publication planning, medical education, and creative and digital solutions. Multidisciplinary teams develop customized, scientifically rigorous communications for healthcare and scientific audiences, including providers, patients, and families, across the product lifecycle.
- Align Evidence Across The Product LifecycleConnects evidence planning and execution with communication expertise to support continuity of outcomes throughout the product lifecycle.
- Communicate Research With Clarity And CredibilitySupports publication goals and communicates research to the right audiences through tailored writing, editing, and publication materials.
- Make Scientific Data Clear And EngagingPresents accurate scientific information through audience-focused design and digital experiences intended to help audiences understand, remember, and act on the data.
- Tailor Evidence To Audience NeedsAdapts scientific communications to the intended audience so complex evidence is presented clearly and appropriately.
- Inform Strategy With Stakeholder PerspectivesUses targeted research to understand stakeholder beliefs, competitor positioning, and evidence needs, and translates those insights into strategies.
- Turn Complex Evidence Into Practical LearningSupports disease understanding, contextualizes emerging data, and promotes knowledge retention and practical application through education formats.
- Support Meaningful Scientific ExchangePlans audience engagement across formats such as congresses, advisory boards, field medical interactions, and digital education.
- Measure And Refine Communication ImpactUses analytics to assess communication impact and inform refinements to creative and digital solutions.
Real-world evidence research and consulting
RTI Health Solutions provides real-world evidence research and consulting to pharmaceutical, biotech, and medical device companies throughout the product lifecycle. Its services include evidence strategy, database and registry research, primary data collection, and research collaborations. The team develops research approaches using real-world data to support product development, regulatory decision-making, market access, reimbursement, safety activities, and outcomes research.
- Guide Evidence Generation Across The Product LifecycleHelps organizations determine how to use real-world data to address research questions and support decisions at different stages of product development and use.
- Turn Real-World Data Into Actionable EvidenceEnables research using database and registry sources to address questions about treatments, diseases, healthcare resource use, and patient outcomes.
- Align Evidence Approaches With Regulatory NeedsHelps clients interpret relevant real-world evidence guidelines and plan research approaches for development, regulatory decision-making, and post-authorization activities.
- Capture Evidence From Patients And Care TeamsSupports observational research that gathers information directly through cohort studies and surveys involving patients, physicians, or caregivers.
- Combine Data And Expertise Across Research PartnersResearch partnerships support multi-country studies and evidence generation on treatment safety and effectiveness, with an emphasis on methodological rigor and transparency.
- Support Post-Authorization Safety And Evidence NeedsProvides study support to address safety, efficacy validation, and regulatory obligations after a product has been authorized.
- Evaluate Treatments With Real-World ComparatorsSupports treatment evaluation by developing external control arm analyses using real-world evidence, including for single-arm trial comparators.
- Design Rigorous Studies For Research ObjectivesHelps translate research questions into study designs and protocols intended to meet scientific and regulatory requirements while considering project constraints.
- Use Clinical Records To Address Research QuestionsHelps clients study clinical chart information as part of real-world research, including when special data protections are required.
- Assess Study Feasibility Before Research BeginsProvides information on practical study requirements and constraints, including timelines, costs, patient availability, and data source reliability.
- Coordinate Pharmacoepidemiology Studies From Planning To DeliverySupports study execution by coordinating pharmacoepidemiologic investigations across their planning and delivery stages.
- Measure Health And Treatment Patterns Over TimeUses cross-sectional and longitudinal surveys to describe current disease and treatment patterns or examine changes in health, treatment response, and outcomes.
- Apply Target Trial Emulation To Real-World DataUses the target trial emulation framework to support real-world data analysis and address methodological challenges.
- Combine Clinical Assessments With Patient InsightsBrings together in-person clinical assessments and structured survey information in observational research.
Medical Affairs Solutions
RTI Health Solutions provides patient-centered medical affairs strategy and services to support evidence-based healthcare decisions and scientific exchange across the product lifecycle. Its multidisciplinary offerings include integrated evidence planning, expert and stakeholder research, medical education, scientific communications, launch readiness, and digital engagement. The work aligns evidence narratives, stakeholder needs, and global and local activities to help scientific innovations reach the right patients in the right context.
- Plan And Generate Integrated EvidenceConnects evidence planning with design, generation, delivery, and communication to support continuity of outcomes throughout the product lifecycle.
- Shape Evidence-Based Medical StrategyDevelops medical strategy and positioning that reflect evidence and stakeholder needs, supporting healthcare decisions and scientific exchange.
- Uncover Stakeholder PerspectivesGathers perspectives from experts, payers, providers, and other stakeholders through primary research and mapping to inform evidence plans and strategy.
- Translate Evidence Into Practical LearningCreates clear, interactive learning experiences intended to promote knowledge retention and practical application, support disease understanding, and inform decisions across the care pathway.
- Support Launch And Lifecycle ReadinessCoordinates medical affairs planning and execution to support product launch and ongoing lifecycle activities.
- Communicate Scientific Evidence ClearlyTurns complex evidence into audience-appropriate scientific communications and content to support understanding and meaningful scientific exchange.
- Align Global, Local, And Cross-Functional TeamsConnects global and local activities and facilitates cross-functional alignment to support coordinated medical affairs planning and execution.
- Plan And Deliver Scientific PublicationsCoordinates publication activities and related content to communicate evidence as part of a broader medical affairs strategy.
- Create Engaging Congress ExperiencesPlans congress activities and develops booth designs and interactives to support scientific engagement with stakeholders.
- Engage Stakeholders And Track ImpactUses online platforms and digital engagement approaches to connect with stakeholders, with metrics and reporting to assess and refine impact.
- Assess Landscape And CompetitorsUses landscape and competitor intelligence to inform medical strategy, positioning, and planning.
- Understand Patient Journeys And SentimentUses patient journey and social sentiment analysis to inform medical affairs planning and stakeholder engagement.
Joint Clinical Assessment Services
RTI Health Solutions provides strategic and technical support to help drug and device developers prepare for and navigate the EU Joint Clinical Assessment process. Services span early planning, submission strategy, evidence generation and synthesis, and dossier preparation. The team helps anticipate assessment scope, address JCA and national HTA interdependencies, and develop robust evidence strategies aligned with stakeholder needs.
- Build A Prepared Submission StrategyDevelops a JCA strategy and preparatory activities for different assessment scenarios, with early consideration of scope, evidence needs, consultation, and organizational readiness.
- Generate Submission-Ready EvidenceDevelops scientifically rigorous evidence for JCA submissions and a credible value story while addressing methodological requirements and stakeholder evidence needs.
- Anticipate Assessment ScopePrepares for likely and appropriate PICOs before final scope is confirmed, enabling focused evidence generation and planning for potential scope or label changes.
- Prepare And Refine JCA DossiersBuilds submission readiness through advance preparation and dossier refinement, with support to adapt materials when final scope or label changes.
- Align Evidence Across RequirementsPlans evidence generation with JCA and national HTA requirements in view, helping teams coordinate their approach across stakeholder needs.
- Gather Coordinated Multi-Country InputObtains coordinated input on clinical development plans before pivotal trial parameters are finalized, with support that can include mock consultations.
- Assess Readiness And Train TeamsEvaluates organizational readiness and provides training to help teams prepare for JCA requirements and submission activities.
Implementation science services
RTI Health Solutions provides multidisciplinary implementation science services to help pharmaceutical, biotech, and medtech companies bridge the gap between clinical development and real-world healthcare adoption. The team combines insights from clinical research, Medical Affairs, real-world evidence, health economics, and stakeholder engagement in a systems-thinking approach. Using established frameworks and rigorous analytics, they identify factors that support or hinder adoption and develop tailored strategies that connect scientific evidence, market dynamics, provider practices, patient perspectives, and policy environments.
- Identify Adoption Barriers EarlyPinpoints factors that may prevent providers, patients, payers, or health systems from adopting a therapy, allowing teams to address real-world challenges proactively.
- Align Teams Around AdoptionConnects expertise and perspectives across relevant functions so implementation considerations are addressed together rather than in silos.
- Plan For Uptake Before LaunchConsiders real-world adoption during development, giving teams the opportunity to use implementation needs to shape evidence generation and care pathway planning before launch.
- Tailor Strategies To Real-World NeedsTranslates findings about adoption conditions into strategies designed for the specific product and its stakeholder, market, and healthcare system context.
- Connect Evidence And Care SystemsAddresses relationships among evidence, stakeholders, market conditions, and healthcare systems to develop implementation strategies suited to the real-world context.
Sources
Methodology and sourcing behind the figures and links shown above.
Health economics and market access consulting
The closest available estimate is the global HEOR market: USD 1.50 billion in 2024, projected to grow at a 13.50% CAGR through 2034. This market includes services beyond consulting, so it is a proxy and may overstate the consulting-only segment.
Real-world evidence
Estimated global market size is USD 3.9 billion in 2025, using Grand View Research’s estimate for real-world evidence solutions, which closely matches the described capabilities. Published estimates vary across providers and market definitions; reported growth rates range from 11.1% to 16.3%. The estimate uses Grand View Research’s 2026–2033 forecast CAGR of 11.1%.
- The global real world evidence solutions market size was valued at USD 3.9 billion in 2025 and is projected to grow from USD 4.3 billion to USD 9.0 billion by 2033, at a CAGR of 11.1%.
- The global real world evidence solutions market was valued at USD 2.6 billion in 2025 and is projected to increase from USD 3.1 billion in 2026 to USD 11.9 billion by 2035, at a CAGR of 16.3%.
Patient-centered outcomes research
The search results provide no standalone estimate for patient-centered outcomes research. The closest quantified proxy is the broader global health economics and outcomes research (HEOR) market, valued at USD 1.50 billion in 2024 and forecast to grow at 13.50% CAGR through 2034. Because the specified segment is narrower than HEOR, USD 1.50 billion should be treated as a broad-market proxy, not a direct segment estimate; the segment's actual size is likely smaller.
Regulatory affairs and drug safety consulting
Estimated global 2025 market for regulatory affairs and drug-safety consulting. The estimate uses the reported USD 5 billion 2025 regulatory consulting market as an anchor, adjusted upward for drug-safety consulting; broader regulatory affairs and pharmacovigilance market figures provide context but include activities beyond consulting. Growth is estimated at 8.5%, consistent with reported regulatory consulting, regulatory affairs, and pharmacovigilance growth rates.
- In 2025, the market for regulatory consulting is projected to reach approximately 5 billion USD, reflecting a compound annual growth rate of around 8 percent.
- The global regulatory affairs market size was reached at USD 17.68 billion in 2025 and is expected to be worth around USD 40.13 billion by 2035, exhibiting a CAGR of 8.54%.
- Market value rises from USD 9 billion in 2025 to USD 9.8 billion in 2026 and USD 22.8 billion by 2036. CAGR 2026 to 2036 8.8%.
Medical affairs and scientific communications
The medical communication services estimate is the closest available proxy for this broader segment, covering scientific communication and related services. It reports a 2026 market size of USD 6.994 billion and a 5.8% CAGR through 2034. Medical writing is a related component, with separate estimates around USD 5.3–5.7 billion, so these figures should not be added to the proxy. The segment estimate is therefore approximate and may not capture all medical strategy and affairs services.
- RTI Health Solutions
- Value, Access, and HEOR Consulting
- Patient-Centered Research
- Regulatory and safety consulting
- Medical Communications
- Real-world evidence research and consulting
- Medical Affairs Solutions
- Joint Clinical Assessment Services
- Implementation science services
- The global health economics and outcomes research market was valued at USD 1.50 Billion in 2024… anticipated to grow at a CAGR of 13.50%
- The global real world evidence solutions market size was valued at USD 3.9 billion in 2025 and is projected to grow from USD 4.3 billion to USD 9.0 billion by 2033, at a CAGR of 11.1%.
- The global real world evidence solutions market was valued at USD 2.6 billion in 2025 and is projected to increase from USD 3.1 billion in 2026 to USD 11.9 billion by 2035, at a CAGR of 16.3%.
- The global health economics and outcomes research market was valued at USD 1.50 Billion in 2024 ... anticipated to grow at a CAGR of 13.50%
- In 2025, the market for regulatory consulting is projected to reach approximately 5 billion USD, reflecting a compound annual growth rate of around 8 percent.
- The global regulatory affairs market size was reached at USD 17.68 billion in 2025 and is expected to be worth around USD 40.13 billion by 2035, exhibiting a CAGR of 8.54%.
- Market value rises from USD 9 billion in 2025 to USD 9.8 billion in 2026 and USD 22.8 billion by 2036. CAGR 2026 to 2036 8.8%.
- Medical Communication Services Market is expected to grow from USD 6,994 million in 2026 to USD 9,749 million by 2034, expanding at a CAGR of 5.8%.
- The Medical Writing Market size was valued at USD 5.33 Billion in 2025 and ... grow at a CAGR of 10.4% from 2025 to 2032.
This is a public preview. Whoever claims it decides what it shows.
This page was built from public information. Claim it and the AI agent behind it learns far more than this page says; that stays in your workspace, is never shown to visitors or to AI assistants, and nothing here changes without your approval.
Own this company? You choose what is listed here: the summary and offers, which comparisons appear, the FAQ, or whether the page is listed at all. Unlisting takes one switch.
Built from public web sources. Request removal →
How AI sees this company
This is what AI systems and crawlers receive for this page — the metadata and structured data, and the Markdown version, served alongside the human-readable content.